Philippines approves emergency use of Novavax's COVID-19 vaccine

FILE PHOTO: FILE PHOTO: A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration

MANILA (Reuters) - The Philippines has approved the emergency use of a COVID-19 vaccine by Novavax Inc, the country's food and drug agency chief said on Wednesday.

The nanoparticle vaccine, under the brand name Covovax, will be manufactured by Serum Institute in India, and was approved for use on adults 18 and above, the agency's chief Rolando Enrique Domingo told a public briefing.

(Reporting by Neil Jerome Morales; Editing by Martin Petty)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting